Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial.

The Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in the Treatment of Advanced Ovarian Cancer

Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer

MtHsp70-CLIC1-pulsed dendritic cells enhance the immune response against ovarian cancer

Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells : Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase

Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells

Cancer Vaccines in Ovarian Cancer: How Can We Improve?

A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.

Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence

[The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer – 229 clinical cases]